Search Results - "Tsopanoglou, Nikos"

Refine Results
  1. 1

    Combined Treatment With Exenatide and Cyclosporine A or Parstatin 1-26 Results in Enhanced Reduction of Infarct Size in a Rabbit Model by Alexopoulos, Panagiotis, Panoutsopoulou, Konstantina, Vogiatzis, George, Koletsis, Efstratios, Dougenis, Dimitrios, Tsopanoglou, Nikos E

    Published in Journal of cardiovascular pharmacology (01-07-2017)
    “…Exenatide and cyclosporine A have been shown to moderately protect against myocardial reperfusion injury leading to reduction of infarct size in patients. Our…”
    Get full text
    Journal Article
  2. 2

    The protease-activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression by Zampatis, Dimitris E., Rutz, Claudia, Furkert, Jens, Schmidt, Antje, Wüstenhagen, Doreen, Kubick, Stefan, Tsopanoglou, Nikos E., Schülein, Ralf

    Published in FEBS letters (30-07-2012)
    “…► We show that the PAR1 possesses a functional and cleaved signal peptide at its N terminus. ► We show that the sequence encoding the signal peptide of the…”
    Get full text
    Journal Article
  3. 3

    Parstatin(1-26): the putative signal peptide of protease-activated receptor 1 confers potent protection from myocardial ischemia-reperfusion injury by Routhu, Kasi V, Tsopanoglou, Nikos E, Strande, Jennifer L

    “…Parstatin, the N-terminal 41-amino-acid peptide cleaved by thrombin from the protease-activated receptor 1, protects against rat myocardial ischemia and…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1 by Tsopanoglou, Nikos E, Maragoudakis, Michael E

    Published in Seminars in thrombosis and hemostasis (01-10-2007)
    “…Angiogenesis, the growth of new blood vessels from preexisting ones, is a necessary component of embryogenesis, wound healing, and the proliferative phase of…”
    Get more information
    Journal Article
  6. 6

    Thrombin's central role in angiogenesis and pathophysiological processes by Tsopanoglou, Nikos E, Maragoudakis, Michael E

    Published in European cytokine network (01-12-2009)
    “…A plethora of endogenous modulators of angiogenesis have been identified and their roles in the molecular and cellular events that mediate and regulate…”
    Get more information
    Journal Article
  7. 7

    Design, synthesis and biological evaluation of new peptide-based ureas and thioureas as potential antagonists of the thrombin receptor PAR1 by Ventosa-Andrés, Pilar, Valdivielso, Ángel M., Pappos, Ioannis, García-López, M. Teresa, Tsopanoglou, Nikos E., Herranz, Rosario

    Published in European journal of medicinal chemistry (01-12-2012)
    “…By applying a diversity oriented synthesis strategy for the search of new antagonists of the thrombin receptor PAR1, a series of peptide-based ureas and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis by Zania, Panagiota, Gourni, Despina, Aplin, Alfred C, Nicosia, Roberto F, Flordellis, Christodoulos S, Maragoudakis, Michael E, Tsopanoglou, Nikos E

    “…The proteolytic activation by thrombin of the proteinase-activated receptor 1 unveils the tethered peptide ligand and cleaves a 41-amino acid peptide. In this…”
    Get more information
    Journal Article
  10. 10

    Role of thrombin in angiogenesis and tumor progression by Tsopanoglou, Nikos E, Maragoudakis, Michael E

    Published in Seminars in thrombosis and hemostasis (01-02-2004)
    “…Clinical, laboratory, histopathological, and pharmacological evidence support the notion that the coagulation system, which is activated in most cancer…”
    Get more information
    Journal Article
  11. 11

    Parstatin suppresses ocular neovascularization and inflammation by Huang, Hu, Vasilakis, Panagiotis, Zhong, Xiufeng, Shen, Ji-Kui, Geronatsiou, Katerina, Papadaki, Helen, Maragoudakis, Michael E, Gartaganis, Sotirios P, Vinores, Stanley A, Tsopanoglou, Nikos E

    “…Parstatin is a 41-mer peptide formed by proteolytic cleavage on activation of the PAR1 receptor. The authors recently showed that parstatin is a potent…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms by Zania, Panagiota, Papaconstantinou, Matthew, Flordellis, Christodoulos S, Maragoudakis, Michael E, Tsopanoglou, Nikos E

    “…Thrombin has been reported to play a pivotal role in the initiation of angiogenesis by indirectly regulating and organizing a network of angiogenic molecules…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury by Strande, Jennifer L., Widlansky, Michael E., Tsopanoglou, Nikos E., Su, Jidong, Wang, JingLi, Hsu, Anna, Routhu, Kasi V., Baker, John E.

    Published in Cardiovascular research (15-07-2009)
    “…Aims Thrombin activates protease-activated receptor 1 by proteolytic cleavage of the N-terminus. Although much research has focused on the activated receptor,…”
    Get full text
    Journal Article
  17. 17

    Thrombin Functions through Its RGD Sequence in a Non-canonical Conformation by Papaconstantinou, Matthew E, Carrell, Christopher J, Pineda, Agustin O, Bobofchak, Kevin M, Mathews, F Scott, Flordellis, Christodoulos S, Maragoudakis, Michael E, Tsopanoglou, Nikos E, Di Cera, Enrico

    Published in The Journal of biological chemistry (19-08-2005)
    “…Previous studies have suggested that thrombin interacts with integrins in endothelial cells through its RGD (Arg-187, Gly-188, Asp-189) sequence. All existing…”
    Get full text
    Journal Article
  18. 18

    On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane components by Tsopanoglou, Nikos E.

    Published in Angiogenesis (London) (01-12-1997)
    “…Human umbilical vein endothelial cells (HUVECs) placed on plastic plates coated with collagen type IV or laminin adhered within 60 min to an extent of about 32…”
    Get full text
    Journal Article
  19. 19

    On the mechanism(s) of thrombin induced angiogenesis by Maragoudakis, M E, Tsopanoglou, N E

    “…Promotion of tumour progression by thrombin is suggested by several clinical and laboratory observations. A plausible explanation for this effect of thrombin…”
    Get more information
    Journal Article
  20. 20

    On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors by Tsopanoglou, N E, Maragoudakis, M E

    Published in The Journal of biological chemistry (20-08-1999)
    “…Many of the cellular actions of thrombin may contribute to the angiogenesis-promoting effect of thrombin reported previously. In this study, we investigated…”
    Get full text
    Journal Article